Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Dong

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potentialDavid R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
A Multitrait Locus Regulates Sarbecovirus PathogenesisAlexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.
Science Translational Medicine|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronavirusesDavid R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Mbio|July 21, 2022
A Multitrait Locus Regulates Sarbecovirus PathogenesisAlexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.
Science Translational Medicine|July 20, 2022
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in miceKenneth H Dinnon, Sarah R Leist, Kenichi Okuda, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategiesKenneth H Dinnon, Sarah R Leist, Kenichi Okuda, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potentialDavid R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
A Multitrait Locus Regulates Sarbecovirus PathogenesisAlexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.
Science Translational Medicine|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronavirusesDavid R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Mbio|July 21, 2022
A Multitrait Locus Regulates Sarbecovirus PathogenesisAlexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.
Science Translational Medicine|July 20, 2022
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in miceKenneth H Dinnon, Sarah R Leist, Kenichi Okuda, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategiesKenneth H Dinnon, Sarah R Leist, Kenichi Okuda, et al.
Pageof 2